AnaptysBio Inc. (ANAB)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) 
$
58. 00
+3.85
+7.1099%
$
2.99B Market Cap
- P/E Ratio
- Div Yield
732,700 Volume
-6.06 Eps
$ 54.15
Previous Close 
Want to track ANAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AnaptysBio Inc. (ANAB) Statistics
Valuation metrics
Market Cap 2.99B
Enterprise value 2.53B
Trailing P/E (ttm) -68.24
Forward P/E -14.65
PEG ratio 0.19
Price/Sales (ttm) 10.76
Price/Book (mrq) 130.55
Enterprise Value/Revenue 10.89
Enterprise Value/EBITDA 43.25
Overview
Shares outstanding 28.02M
Float 17.26M
Shares short 4.81M
% Held by insiders 0.06%
% Held by institutions 1.01%
Average volume (10 days) 534.64K
Average volume (90 days) 678.91K
Price summary
52-Week low 11.4
52-Week high 72.36
Beta 0.41
50-Day moving average 61.54
200-Day moving average 44.35
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 15:10
Last split Date 20 Apr 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.12%
Operating margin 0.18%
Operational effectiveness
Return on assets -0.08%
Return on equity 4.43%
Income Statement
Revenue (ttm) 234.6M
Revenue per share (ttm) 8.1
Quarterly revenue growth (yoy) 1.51%
Gross profit (ttm) 98.63M
EBITDA 69.25M
Net income to common (ttm) -13.23M
Diluted EPS (ttm) -0.93
Quarterly earnings growth (yoy) 1.51%
Balance Sheet
Total cash (mrq) 311.64M
Total cash per share (mrq) 9.98
Total debt (mrq) 290.64M
Total Debt/Equity (mrq) 21.76
Current ratio (mrq) 7.58%
Book value per share (mrq) 0.44
Cash Flow
Cash flow statement 19.7M
Levered free cash flow (LFCF) 19.34M
